An Observational, Prospective, Safety Study of Mircera (Monopegylated Epoetin Beta) in Clinical Practice

Clinical trial NCT02263833 · COMPLETED

Trial details

NCT number: NCT02263833
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Kidney Disease, Chronic

Start date: 2009-09-01
Primary completion: 2012-08-01
Enrollment: 748

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.